27.04.2023 • News

Radici Opens China Polymer Plant

Italian polyamide and polymer specialist Radici has opened a new manufacturing plant in Suzhou, China, stepping up its presence in the Asian market. The site is designed to double capacity for engineering polymers, serving various markets that include automotive, electrical/electronics, consumer and industrial goods.

The new RadiciGroup industrial site in Suzhou, China.© RadiciGroup
The new RadiciGroup industrial site in Suzhou, China.© RadiciGroup

Radici has invested €35 million in developing the location, which also incorporates R&D facilities. The complex is gold-certified by Leadership in Energy and Environmental Design (LEED), a global green building certification program developed by the U.S. Green Building Council.

“Since starting up manufacturing operations in China more than fifteen years ago, we have grown immensely, together with the local market. Our materials are used by customers that in turn manufacture in China to satisfy the needs of local consumers,” said president Angelo Radici. He added that “some of the solutions that we research and develop in China become benchmarks for the entire Group, thanks to our international network.”

The Bergamo-headquartered company has been producing in China since 2006, when it first opened a small plant in Jiangsu province. In 2012 it moved to a larger site, before building its latest facility, which is capable of being scaled up in the future, as required.

Author: Elaine Burridge, Freelance Journalist

Article

The State of the US Specialty Chemicals Industry
Reshaping Specialty Chemicals Manufacturing

The State of the US Specialty Chemicals Industry

SOCMA's Jenn Klein examines how specialty chemical manufacturers — the invisible backbone behind pharmaceuticals, electronics, agriculture, and energy — are navigating supply chain shifts, policy uncertainty, and constant change while remaining resilient, disciplined, and focused on execution.

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

most read

Photo

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.